Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
YUVEZZI (BRIMONIDINE TARTRATE; CARBACHOL) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
YUVEZZI
NDA
Get alerts
BRIMONIDINE TARTRATE; CARBACHOL | N220142 | VISUS THERAPEUTICS INC
1 strength
2 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
2 unique patents, 1 exclusivity by expiration date
Active (2)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
8455494
May. 24, 2030
12268662
Nov. 10, 2042
NP
Jan. 28, 2029
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 0.1%;2.75%
RLD
2 patents
1 exclusivity
▴
SOLUTION/DROPS;OPHTHALMIC | Approved: Jan 28, 2026
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8455494
May 24, 2030
—
—
—
U-3741
TREATMENT OF PRESBYOPIA
—
12268662
Nov 10, 2042
—
—
Yes
U-3741
TREATMENT OF PRESBYOPIA
—
Exclusivities (1)
Code
Date
Status
NP
Jan 28, 2029
Active